Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Ethosuximide
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ethosuximide 250mg capsules
0408010I0AAAAAA
|
Ethosuximide | Ethosuximide | Central Nervous System | 7,859 |
|
Ethosuximide 250mg/5ml oral solution
0408010I0AAABAB
|
Ethosuximide | Ethosuximide | Central Nervous System | 3,241 |
|
Ethosuximide 250mg/5ml oral solution sugar free
0408010I0AAAKAK
|
Ethosuximide | Ethosuximide | Central Nervous System | 1,541 |
|
Epesri 250mg capsules
0408010I0BDAAAA
|
Epesri | Ethosuximide | Central Nervous System | 973 |
|
Emeside 250mg capsules
0408010I0BBAAAA
|
Emeside | Ethosuximide | Central Nervous System | 954 |
|
Emeside 250mg/5ml syrup
0408010I0BBABAB
|
Emeside | Ethosuximide | Central Nervous System | 467 |
|
Ethosuximide 500mg/5ml oral solution sugar free
0408010I0AAALAL
|
Ethosuximide | Ethosuximide | Central Nervous System | No data available |
|
Zarontin 250mg capsules
0408010I0BCAAAA
|
Zarontin | Ethosuximide | Central Nervous System | No data available |
|
Zarontin 250mg/5ml syrup
0408010I0BCABAB
|
Zarontin | Ethosuximide | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.